Gain-of-function STAT1 mutation and visceral leishmaniasis
Einstein (Säo Paulo)
; 20: eRC0048, 2022. tab
Article
in En
|
LILACS-Express
| LILACS
| ID: biblio-1404676
Responsible library:
BR1.1
ABSTRACT
ABSTRACT Gain-of-function mutations in the STAT1 gene have been initially associated with chronic mucocutaneous candidiasis. However, further research has shown that STAT1 GOF variants may increase susceptibility to infection by other intracellular pathogens. This report describes the first case of disseminated leishmaniasis associated with a STAT1 GOF mutation in a pediatric patient who did not have chronic mucocutaneous candidiasis. The patient was a four-year-old boy presenting with fever, severe asthenia, hepatosplenomegaly, pancytopenia, and liver failure. Bone marrow aspirate revealed hemophagocytosis and Leishmania parasites. Treatment consisted primarily of liposomal amphotericin B, as per the Hemophagocytic Lymphohistiocytosis 2004 protocol. After eight weeks of treatment, the patient did not improve and was submitted to diagnostic splenectomy. Activated macrophages and nodular spleen necrosis secondary to the visceral leishmaniasis were detected. Unfortunately, the patient died in the second week after splenectomy due to overwhelming systemic infection. DNA sequencing revealed a pathogenic (p. R274Q) GOF mutation in STAT1.
Full text:
1
Collection:
01-internacional
Database:
LILACS
Type of study:
Guideline
Language:
En
Journal:
Einstein (Säo Paulo)
Journal subject:
MEDICINA
Year:
2022
Document type:
Article
Affiliation country:
Brazil
Country of publication:
Brazil